Vibrio species: development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints

ConclusionsWe demonstrated the validity of using standard BMD and EUCAST disc diffusion methodology for AST of fiveVibrio spp., and generated suitable data to allow EUCAST to determine clinical MIC and zone diameter breakpoints for five pathogenicVibrio spp., including both non-toxigenic and toxigenicV. cholerae.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research